Stemgent, Inc.
Stem cell lines and reagents for drug discovery research
- Sector
- Biotech
- Headquarters
- CAMBRIDGE, MA
- Founded
- 2007
- Latest Form D
- $11.3M, Aug 2012
- Total capital
- $27.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $27.3M
- 6 Form D · last Aug 2012
- 171 months since last filing
- Federal contracts
- $400K
- 12 awards · Health and Human S, Veterans Affairs
- Rank in Biotech#241 of 4373
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Igf::ot::igf$24K
- Federal contractHealth and Human S · Laboratory Equipment And Supplies$25K
- Federal contractVeterans Affairs · Biologicals$10K
- Federal contractVeterans Affairs · Supply Order Of Activin A For Research Department At Va San Diego Medical Center$15K
- Private capital raisedForm D · SEC · 6th filing$11.3M
- Federal contractHealth and Human S · Ips Cell Lines; Stemgent, INC.:1180989$64K
- Federal contractVeterans Affairs · Medical Supplies For Research Dept.$16K
- Private capital raisedForm D · SEC · 5th filing$6.3M
- Private capital raisedForm D · SEC · 4th filing$585K
- Private capital raisedForm D · SEC · 3rd filing$750K
- Private capital raisedForm D · SEC · 2nd filing$5.6M
- Private capital raisedForm D · SEC · 1st filing$2.7M
Show 5 earlier federal awards
- Federal contractHealth and Human S · TAS::75 0884::TAS Catalog # 10-0013-1 Cell Screening And Quaratine$11K
- Federal contractHealth and Human S · TAS::75 0862::TAS 10-0013-1 Cell Screening And Quarantine; Quote: Ref. Anton Jetten$14K
- Federal contractHealth and Human S · Cell Quarantine$27K
- Federal contractHealth and Human S · TAS::75 0888::TAS Tuition/reg/memb Fees$98K
- Federal contractHealth and Human S · TAS::75 0888::TAS Stem Cell Training$96K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Founders and team
From SEC Form D filings- Augustine E. LawlorDirectorNamed in SEC Form D filings
- Harold R. WernerDirectorNamed in SEC Form D filings
- Ian RatcliffeExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Ralph E. ChristoffersenDirectorNamed in SEC Form D filings
- Stefan E. MiltenyiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingMethods Of Preparing Pluripotent Stem CellsUSPTOApplication 14567968
- PendingMethods Of Preparing Pluripotent Stem CellsUSPTOApplication PCTUS2013045686
Related companies, and why
- Litron Laboratories LtdSimilar federal contract value in Biotech · $426K in contracts
- Cell Surgical Network CorporationSimilar federal contract value in Biotech · $413K in contracts
- ExelixisSimilar federal contract value in Biotech · $401K in contracts
- RIPTIDE THERAPEUTICS LLCSimilar federal contract value in Biotech · $400K in contracts
- TRITERPENOID THERAPEUTICS INCSimilar federal contract value in Biotech · $400K in contracts
- ENRICH BIOSYSTEMS INCSimilar federal contract value in Biotech · $400K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .